Gene name:
CILP (UNQ602/PRO1188) ;
Protein name:
Cartilage intermediate layer protein 1 (CILP-1) ;
Alternative:
Cartilage intermediate-layer protein ;
Organism:
Human (Homo sapiens).
General Annotation
Sub Unit:
Monomer. Interacts with TGFB1.
Function:
Probably plays a role in cartilage scaffolding. May act by antagonizing TGF-beta1 (TGFB1) and IGF1 functions. Has the ability to suppress IGF1-induced proliferation and sulfated proteoglycan synthesis, and inhibits ligand-induced IGF1R autophosphorylation. May inhibit TGFB1-mediated induction of cartilage matrix genes via its interaction with TGFB1. Overexpression may lead to impair chondrocyte growth and matrix repair and indirectly promote inorganic pyrophosphate (PPi) supersaturation in aging and osteoarthritis cartilage.
Subcellular Location:
Secreted
extracellular space
extracellular matrix
Protein Attributes:
50:
MVGTKAWVFS | FLVLEVTSVL | GRQTMLTQSV | RRVQPGKKNP | SIFAKPADTL |
100:
ESPGEWTTWF | NIDYPGGKGD | YERLDAIRFY | YGDRVCARPL | RLEARTTDWT |
150:
PAGSTGQVVH | GSPREGFWCL | NREQRPGQNC | SNYTVRFLCP | PGSLRRDTER |
200:
IWSPWSPWSK | CSAACGQTGV | QTRTRICLAE | MVSLCSEASE | EGQHCMGQDC |
250:
TACDLTCPMG | QVNADCDACM | CQDFMLHGAV | SLPGGAPASG | AAIYLLTKTP |
300:
KLLTQTDSDG | RFRIPGLCPD | GKSILKITKV | KFAPIVLTMP | KTSLKAATIK |
350:
AEFVRAETPY | MVMNPETKAR | RAGQSVSLCC | KATGKPRPDK | YFWYHNDTLL |
400:
DPSLYKHESK | LVLRKLQQHQ | AGEYFCKAQS | DAGAVKSKVA | QLIVIASDET |
450:
PCNPVPESYL | IRLPHDCFQN | ATNSFYYDVG | RCPVKTCAGQ | QDNGIRCRDA |
500:
VQNCCGISKT | EEREIQCSGY | TLPTKVAKEC | SCQRCTETRS | IVRGRVSAAD |
550:
NGEPMRFGHV | YMGNSRVSMT | GYKGTFTLHV | PQDTERLVLT | FVDRLQKFVN |
600:
TTKVLPFNKK | GSAVFHEIKM | LRRKKPITLE | AMETNIIPLG | EVVGEDPMAE |
650:
LEIPSRSFYR | QNGEPYIGKV | KASVTFLDPR | NISTATAAQT | DLNFINDEGD |
700:
TFPLRTYGMF | SVDFRDEVTS | EPLNAGKVKV | HLDSTQVKMP | EHISTVKLWS |
750:
LNPDTGLWEE | EGDFKFENQR | RNKREDRTFL | VGNLEIRERR | LFNLDVPESR |
800:
RCFVKVRAYR | SERFLPSEQI | QGVVISVINL | EPRTGFLSNP | RAWGRFDSVI |
850:
TGPNGACVPA | FCDDQSPDAY | SAYVLASLAG | EELQAVESSP | KFNPNAIGVP |
900:
QPYLNKLNYR | RTDHEDPRVK | KTAFQISMAK | PRPNSAEESN | GPIYAFENLR |
950:
ACEEAPPSAA | HFRFYQIEGD | RYDYNTVPFN | EDDPMSWTED | YLAWWPKPME |
1000:
FRACYIKVKI | VGPLEVNVRS | RNMGGTHRQT | VGKLYGIRDV | RSTRDRDQPN |
1050:
VSAACLEFKC | SGMLYDQDRV | DRTLVKVIPQ | GSCRRASVNP | MLHEYLVNHL |
1100:
PLAVNNDTSE | YTMLAPLDPL | GHNYGIYTVT | DQDPRTAKEI | ALGRCFDGTS |
1150:
DGSSRIMKSN | VGVALTFNCV | ERQVGRQSAF | QYLQSTPAQS | PAAGTVQGRV |
1184:
PSRRQQRASR | GGQRQGGVVA | SLRFPRVAQQ | PLIN
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Mouse
Human
Pig
ELISA Kit for Human CILP-1
ELISA Kit for Human CILP-1
ELISA Kit for Human CILP-1
CLIA Kit for Human CILP-1
CLIA Kit for Human CILP-1
CLIA Kit for Human CILP-1
Polyclonal Antibody for Human CILP-1
Polyclonal Antibody for Human CILP-1
Polyclonal Antibody for Human CILP-1
Monoclonal Antibody for Human CILP-1
Monoclonal Antibody for Human CILP-1
Monoclonal Antibody for Human CILP-1
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
References
1.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA];PROTEIN SEQUENCE OF 39-58; 282-291; 301-317; 332-338; 341-356; 361-365; 524-547; 575-594; 680-690 AND 698-707;GLYCOSYLATION AT ASN-346;PROTEOLYTIC PROCESSING;TISSUE SPECIFICITY;VARIANTS LEU-59; THR-395; GLU-575; ARG-979 AND SER-1166
tissue :
Articular cartilage .
2.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANTS LEU-59; PHE-327; THR-395; GLU-575; VAL-895; ARG-979; ASN-1101; SER-1166 AND ALA-1168
3.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANTS LEU-59; THR-395; GLU-575; ARG-979 AND SER-1166
4.
"The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment."
Clark H.F.
,
Gurney A.L.
,
Abaya E.
,
Baker K.
,
Baldwin D.T.
,
Brush J.
,
Chen J.
,
Chow B.
,
Chui C.
,
Crowley C.
,
Currell B.
,
Deuel B.
,
Dowd P.
,
Eaton D.
,
Foster J.S.
,
Grimaldi C.
,
Gu Q.
,
Hass P.E.
,
Heldens S.
,
Huang A.
,
Kim H.S.
,
Klimowski L.
,
Jin Y.
,
Johnson S.
,
Lee J.
,
Lewis L.
,
Liao D.
,
Mark M.R.
,
Robbie E.
,
Sanchez C.
,
Schoenfeld J.
,
Seshagiri S.
,
Simmons L.
,
Singh J.
,
Smith V.
,
Stinson J.
,
Vagts A.
,
Vandlen R.L.
,
Watanabe C.
,
Wieand D.
,
Woods K.
,
Xie M.-H.
,
Yansura D.G.
,
Yi S.
,
Yu G.
,
Yuan J.
,
Zhang M.
,
Zhang Z.
,
Goddard A.D.
,
Wood W.I.
,
Godowski P.J.
,
Gray A.M.
more...
Genome Res.13:2265-2270(2003)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA];VARIANTS THR-395; GLU-575 AND ARG-979
5.
"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T.
,
Suzuki Y.
,
Nishikawa T.
,
Otsuki T.
,
Sugiyama T.
,
Irie R.
,
Wakamatsu A.
,
Hayashi K.
,
Sato H.
,
Nagai K.
,
Kimura K.
,
Makita H.
,
Sekine M.
,
Obayashi M.
,
Nishi T.
,
Shibahara T.
,
Tanaka T.
,
Ishii S.
,
Yamamoto J.
,
Saito K.
,
Kawai Y.
,
Isono Y.
,
Nakamura Y.
,
Nagahari K.
,
Murakami K.
,
Yasuda T.
,
Iwayanagi T.
,
Wagatsuma M.
,
Shiratori A.
,
Sudo H.
,
Hosoiri T.
,
Kaku Y.
,
Kodaira H.
,
Kondo H.
,
Sugawara M.
,
Takahashi M.
,
Kanda K.
,
Yokoi T.
,
Furuya T.
,
Kikkawa E.
,
Omura Y.
,
Abe K.
,
Kamihara K.
,
Katsuta N.
,
Sato K.
,
Tanikawa M.
,
Yamazaki M.
,
Ninomiya K.
,
Ishibashi T.
,
Yamashita H.
,
Murakawa K.
,
Fujimori K.
,
Tanai H.
,
Kimata M.
,
Watanabe M.
,
Hiraoka S.
,
Chiba Y.
,
Ishida S.
,
Ono Y.
,
Takiguchi S.
,
Watanabe S.
,
Yosida M.
,
Hotuta T.
,
Kusano J.
,
Kanehori K.
,
Takahashi-Fujii A.
,
Hara H.
,
Tanase T.-O.
,
Nomura Y.
,
Togiya S.
,
Komai F.
,
Hara R.
,
Takeuchi K.
,
Arita M.
,
Imose N.
,
Musashino K.
,
Yuuki H.
,
Oshima A.
,
Sasaki N.
,
Aotsuka S.
,
Yoshikawa Y.
,
Matsunawa H.
,
Ichihara T.
,
Shiohata N.
,
Sano S.
,
Moriya S.
,
Momiyama H.
,
Satoh N.
,
Takami S.
,
Terashima Y.
,
Suzuki O.
,
Nakagawa S.
,
Senoh A.
,
Mizoguchi H.
,
Goto Y.
,
Shimizu F.
,
Wakebe H.
,
Hishigaki H.
,
Watanabe T.
,
Sugiyama A.
,
Takemoto M.
,
Kawakami B.
,
Yamazaki M.
,
Watanabe K.
,
Kumagai A.
,
Itakura S.
,
Fukuzumi Y.
,
Fujimori Y.
,
Komiyama M.
,
Tashiro H.
,
Tanigami A.
,
Fujiwara T.
,
Ono T.
,
Yamada K.
,
Fujii Y.
,
Ozaki K.
,
Hirao M.
,
Ohmori Y.
,
Kawabata A.
,
Hikiji T.
,
Kobatake N.
,
Inagaki H.
,
Ikema Y.
,
Okamoto S.
,
Okitani R.
,
Kawakami T.
,
Noguchi S.
,
Itoh T.
,
Shigeta K.
,
Senba T.
,
Matsumura K.
,
Nakajima Y.
,
Mizuno T.
,
Morinaga M.
,
Sasaki M.
,
Togashi T.
,
Oyama M.
,
Hata H.
,
Watanabe M.
,
Komatsu T.
,
Mizushima-Sugano J.
,
Satoh T.
,
Shirai Y.
,
Takahashi Y.
,
Nakagawa K.
,
Okumura K.
,
Nagase T.
,
Nomura N.
,
Kikuchi H.
,
Masuho Y.
,
Yamashita R.
,
Nakai K.
,
Yada T.
,
Nakamura Y.
,
Ohara O.
,
Isogai T.
,
Sugano S.
more...
Nat. Genet.36:40-45(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA];VARIANTS THR-395; GLU-575; ARG-979 AND SER-1166
tissue :
Testis .
6.
"Analysis of the DNA sequence and duplication history of human chromosome 15."
Zody M.C.
,
Garber M.
,
Sharpe T.
,
Young S.K.
,
Rowen L.
,
O'Neill K.
,
Whittaker C.A.
,
Kamal M.
,
Chang J.L.
,
Cuomo C.A.
,
Dewar K.
,
FitzGerald M.G.
,
Kodira C.D.
,
Madan A.
,
Qin S.
,
Yang X.
,
Abbasi N.
,
Abouelleil A.
,
Arachchi H.M.
,
Baradarani L.
,
Birditt B.
,
Bloom S.
,
Bloom T.
,
Borowsky M.L.
,
Burke J.
,
Butler J.
,
Cook A.
,
DeArellano K.
,
DeCaprio D.
,
Dorris L. III
,
Dors M.
,
Eichler E.E.
,
Engels R.
,
Fahey J.
,
Fleetwood P.
,
Friedman C.
,
Gearin G.
,
Hall J.L.
,
Hensley G.
,
Johnson E.
,
Jones C.
,
Kamat A.
,
Kaur A.
,
Locke D.P.
,
Madan A.
,
Munson G.
,
Jaffe D.B.
,
Lui A.
,
Macdonald P.
,
Mauceli E.
,
Naylor J.W.
,
Nesbitt R.
,
Nicol R.
,
O'Leary S.B.
,
Ratcliffe A.
,
Rounsley S.
,
She X.
,
Sneddon K.M.B.
,
Stewart S.
,
Sougnez C.
,
Stone S.M.
,
Topham K.
,
Vincent D.
,
Wang S.
,
Zimmer A.R.
,
Birren B.W.
,
Hood L.
,
Lander E.S.
,
Nusbaum C.
more...
Nature440:671-675(2006)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
7.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA];VARIANTS GLU-575; ARG-979 AND SER-1166
tissue :
Ovary .
8.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : SUBUNIT;GLYCOSYLATION;TISSUE SPECIFICITY
9.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : TISSUE SPECIFICITY
10.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INVOLVEMENT IN OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS
11.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : FUNCTION
12.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : IMMUNISATION
13.
"The prevalence of autoantibodies against cartilage intermediate layer protein, YKL-39, osteopontin, and cyclic citrullinated peptide in patients with early-stage knee osteoarthritis: evidence of a variety of autoimmune processes."
Du H.
,
Masuko-Hongo K.
,
Nakamura H.
,
Xiang Y.
,
Bao C.-D.
,
Wang X.-D.
,
Chen S.-L.
,
Nishioka K.
,
Kato T.
Rheumatol. Int.26:35-41(2005)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INVOLVEMENT IN OSTEOARTHRITIS
14.
"A functional SNP in CILP, encoding cartilage intermediate layer protein, is associated with susceptibility to lumbar disc disease."
Seki S.
,
Kawaguchi Y.
,
Chiba K.
,
Mikami Y.
,
Kizawa H.
,
Oya T.
,
Mio F.
,
Mori M.
,
Miyamoto Y.
,
Masuda I.
,
Tsunoda T.
,
Kamata M.
,
Kubo T.
,
Toyama Y.
,
Kimura T.
,
Nakamura Y.
,
Ikegawa S.
Nat. Genet.37:607-612(2005)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : FUNCTION;SUBCELLULAR LOCATION;TISSUE SPECIFICITY;INTERACTION WITH TGFB1;ASSOCIATION OF VARIANT THR-395 WITH SUSCEPTIBILITY TO INTERVERTEBRAL DISK DISEASE
15.
"Diagnostic exome sequencing in persons with severe intellectual disability."
de Ligt J.
,
Willemsen M.H.
,
van Bon B.W.
,
Kleefstra T.
,
Yntema H.G.
,
Kroes T.
,
Vulto-van Silfhout A.T.
,
Koolen D.A.
,
de Vries P.
,
Gilissen C.
,
del Rosario M.
,
Hoischen A.
,
Scheffer H.
,
de Vries B.B.
,
Brunner H.G.
,
Veltman J.A.
,
Vissers L.E.
N. Engl. J. Med.367:1921-1929(2012)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS HIS-495 AND THR-1032